Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Evoke Pharma (EVOK)
NASDAQ:EVOK
Holding EVOK?
Track your performance easily
EVOK Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.54 - $18.59
Previous Close$4.24
Volume60.43K
Average Volume (3M)61.39K
Market Cap
$3.47M
Enterprise Value-$726.29K
Total Cash (Recent Filing)$9.20M
Total Debt (Recent Filing)$5.00M
Price to Earnings (P/E)―
Beta0.62
Next Earnings
Nov 07, 2024EPS Estimate
-$0.38Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-16.23
Shares Outstanding734,836
10 Day Avg. Volume11,322
30 Day Avg. Volume61,387
Standard Deviation0.28
R-Squared0.00499
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)1.17
Price to Sales (P/S)0.43
Price to Cash Flow (P/CF)-1.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-0.10
Enterprise Value/Gross Profit-0.15
Enterprise Value/Ebitda0.13
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Evoke Pharma News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
EVOK FAQ
What was Evoke Pharma’s price range in the past 12 months?
Evoke Pharma lowest stock price was $3.54 and its highest was $18.59 in the past 12 months.
What is Evoke Pharma’s market cap?
Currently, no data Available
When is Evoke Pharma’s upcoming earnings report date?
Evoke Pharma’s upcoming earnings report date is Nov 07, 2024 which is in 48 days.
How were Evoke Pharma’s earnings last quarter?
Evoke Pharma released its earnings results on Aug 13, 2024. The company reported -$0.93 earnings per share for the quarter, missing the consensus estimate of -$0.72 by -$0.21.
Is Evoke Pharma overvalued?
According to Wall Street analysts Evoke Pharma’s price is currently Overvalued.
Does Evoke Pharma pay dividends?
Evoke Pharma does not currently pay dividends.
What is Evoke Pharma’s EPS estimate?
Evoke Pharma’s EPS estimate is -$0.38.
How many shares outstanding does Evoke Pharma have?
Evoke Pharma has 819,272 shares outstanding.
What happened to Evoke Pharma’s price movement after its last earnings report?
Evoke Pharma reported an EPS of -$0.93 in its last earnings report, missing expectations of -$0.72. Following the earnings report the stock price went up 0.879%.
Which hedge fund is a major shareholder of Evoke Pharma?
Currently, no hedge funds are holding shares in EVOK
---
Evoke Pharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
EVOK Sentiment 100%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-69.54%
12-Months-Change
Fundamentals
Return on Equity
-407.60%
Trailing 12-Months
Asset Growth
35.15%
Trailing 12-Months
Company Description
Evoke Pharma
Evoke Pharma, Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It develops Gimoti, with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded by Matthew J. D'Onofrio, Cam L. Garner, Scott L. Glenn, and David A. Gonyer in January 2007 and is headquartered in Solana Beach, CA.
---
EVOK Earnings Call
Q4 2024
0:00 / 0:00
---
Technical Analysis
---